Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bionerv is an oral, film-coated tablet containing a fixed-dose combination of alpha lipoic acid (300mg), vitamin B12 (methylcobalamin 500mcg), vitamin B6 (pyridoxine 8mg), and vitamin B1 (thiamine 39mg). It is manufactured by BREGO Life Sciences Sdn Bhd and is being investigated for the treatment of diabetic polyneuropathy in individuals with type 2 diabetes mellitus. The product is described as the first combination of alpha lipoic acid and vitamin B complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bionerv.